NCT00480987: Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS) |
|
|
| Terminated | 1/2 | 27 | US | Oxaliplatin, Eloxatin®, Fludarabine, Fludara®, Fludarabine Phosphate, Cytarabine, Ara-C | M.D. Anderson Cancer Center, Sanofi | Myelodysplastic Syndromes, Acute Myeloid Leukemia, Leukemia | 08/10 | 08/10 | | |
